plavix

(MedPage Today) -- The labeling on the proton-pump inhibitor dexlansoprazole (Dexilant) has been updated to reflect its compatibility with clopidogrel (Plavix), according to Takeda, the drug's maker.

SAN FRANCISCO (MedPage Today) -- The novel fast-acting IV antiplatlet drug cangrelor provided an effective bridge for patients on thienopyridine therapy, including clopidogrel (Plavix), who required bypass surgery, according to results of the late-breaking BRIDGE trial.

The benefits of using a common class of heartburn drugs in combination with antiplatelet therapy in people with heart disease outweighs the risk for most people with a history of gastrointestinal (GI) problems, according to new guidelines.

(McMaster University) New findings by McMaster University researchers contradict earlier reports that people with a certain genetic make-up don't benefit from the blood-thinner clopidogrel, also known as Plavix.

(MedPage Today) -- Almost 90% of percutaneous coronary intervention patients with an altered platelet reactivity genotype responded to tailored clopidogrel (Plavix) therapy, French investigators reported.

The anti-clotting drug Plavix will get a new "black box" label warning that normal doses don't work for 2% to 14% of patients.

WASHINGTON (AP) -- In a Nov. 17 story about drug interactions between heartburn medications and the blood thinner Plavix, The Associated Press misidentified Johnson & Johnson's Mylanta as part of the H-2 blocker drug family.

Mylanta is an antacid....

WASHINGTON (AP) -- Federal health officials said Tuesday a popular heartburn medication can interfere with the blood thinner Plavix, a drug taken by millions of Americans to reduce risks of heart attack and stroke....

WASHINGTON (AP) -- Federal health officials are investigating whether the blood thinner Plavix - the world's second-best-selling drug and used by millions to reduce the risk of heart attack and stroke - may be less effective in some patients....

PARIS (MedPage Today) -- For the small percentage of MI patients younger than 45 who are homozygous for a certain gene variant, clopidogrel (Plavix) may be significantly less effective in secondary prevention, researchers reported here.